Table 4.

Nonhematologic side effects; n = 60


Side effect

Grade 2 or lower (%)

Grade 3 or higher (%)
Diarrhea   40 (67)   3 (5)  
Nausea   40 (67)   1 (2)  
Headache   40 (67)   —  
Rash   38 (63)   11 (18) 
Hyperbilirubinemia   35 (58)   9 (15)  
Flushing*  35 (58)   1 (2)  
Vomiting   31 (52)   —  
Mucositis   30 (50)   2 (3)  
ALT/AST elevation   28 (47)   10 (17)  
Palmoplantar erythrodysesthesia  22 (37)   2 (3)  
Elevations of alkaline phosphatase   10 (17)   1 (2)  
Extremity edema   9 (15)   1 (2)  
Fatigue   9 (15)   —  
Pruritus   7 (12)   —  
Elevation of creatinine   6 (10)   —  
Ageusia
 
6 (10)
 

 

Side effect

Grade 2 or lower (%)

Grade 3 or higher (%)
Diarrhea   40 (67)   3 (5)  
Nausea   40 (67)   1 (2)  
Headache   40 (67)   —  
Rash   38 (63)   11 (18) 
Hyperbilirubinemia   35 (58)   9 (15)  
Flushing*  35 (58)   1 (2)  
Vomiting   31 (52)   —  
Mucositis   30 (50)   2 (3)  
ALT/AST elevation   28 (47)   10 (17)  
Palmoplantar erythrodysesthesia  22 (37)   2 (3)  
Elevations of alkaline phosphatase   10 (17)   1 (2)  
Extremity edema   9 (15)   1 (2)  
Fatigue   9 (15)   —  
Pruritus   7 (12)   —  
Elevation of creatinine   6 (10)   —  
Ageusia
 
6 (10)
 

 

—indicates not applicable.

*

Infusion related.

Hand-foot syndrome.

Including one patient with Stevens-Johnson syndrome.

Close Modal

or Create an Account

Close Modal
Close Modal